Stay updated with breaking news from Hyperfine Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hyperfine, Inc. announced completed enrollment for the multi-site observational study, HOPE PMR . Children living with hydrocephalus typically undergo at least two brain scans per year to monitor...
Multi-site observational study seeks to redefine the standard of care for pediatric hydrocephalus managementÂ
Hyperfine (NASDAQ:HYPR – Get Free Report) and CONMED (NYSE:CNMD – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations. Analyst Ratings This is a summary of recent ratings and […]
CONMED (NYSE:CNMD – Get Free Report) and Hyperfine (NASDAQ:HYPR – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Institutional & Insider Ownership 13.0% of Hyperfine shares are owned […]
Hyperfine (NASDAQ:HYPR – Get Free Report) and Nexalin Technology (NASDAQ:NXL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Analyst Recommendations This is a breakdown of recent […]